Victor Albarran

Barcelona, CT 08036, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

DNA damage response pathway alterations in urothelial carcinoma: a road to precision oncology or a dead-end street?

DNA damage response pathway alterations in urothelial carcinoma: a road to precision oncology or a dead-end street?

Journal: The oncologist

Published: May 11, 2026

Expression of LIFR in tumor and SHOC2, YAP1 in plasma mRNA as potential biomarkers in KRAS G12C NSCLC.

Expression of LIFR in tumor and SHOC2, YAP1 in plasma mRNA as potential biomarkers in KRAS G12C NSCLC.

Journal: Scientific reports

Published: February 19, 2026

Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer.

Single nucleotide polymorphisms: impact on susceptibility to chemotherapy in patients with colorectal cancer.

Journal: Future science OA

Published: November 22, 2024

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients.

Journal: The oncologist

Published: April 15, 2024

Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent.

Negative association of steroids with immunotherapy efficacy in a multi-tumor cohort: time and dose-dependent.

Journal: Cancer immunology, immunotherapy : CII

Published: March 24, 2024

Adoptive T cell therapy for solid tumors: current landscape and future challenges.

Adoptive T cell therapy for solid tumors: current landscape and future challenges.

Journal: Frontiers in immunology

Published: December 08, 2023

BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature.

BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature.

Journal: Cancers

Published: September 25, 2023

Recurrent Glioblastoma: A Review of the Treatment Options.

Recurrent Glioblastoma: A Review of the Treatment Options.

Journal: Cancers

Published: June 28, 2023

Current Landscape of Immunotherapy for Advanced Sarcoma.

Current Landscape of Immunotherapy for Advanced Sarcoma.

Journal: Cancers

Published: March 18, 2023

Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature.

Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature.

Journal: Frontiers in oncology

Published: February 04, 2023

Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.

Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.

Journal: International journal of molecular sciences

Published: October 06, 2022

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.

Journal: International journal of molecular sciences

Published: September 28, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026